NCT06131970

Brief Summary

There are different treatment for chronic pain. One possible treatment is intravenous infusions of ketamine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 22, 2022

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

November 7, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 15, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 6, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 6, 2024

Completed
Last Updated

February 19, 2025

Status Verified

February 1, 2025

Enrollment Period

2.5 years

First QC Date

November 7, 2023

Last Update Submit

February 17, 2025

Conditions

Chronic Pain

Keywords

PainNeuropathic painChronic painFibromyalgiaMusculoskeletal diseases

Outcome Measures

Primary Outcomes (2)

  • Long-term effectiveness

    Improvement of the numerical scale - score 0 to 10 - 10 is the worst

    1 month

  • Long-term effectiveness

    Clinical Global Impression of Change (CGI-C) - score 1 to 7 - 7 is the worst

    1 month

Secondary Outcomes (3)

  • Pain relief

    15, 30, 60 days

  • Variation of quality of life

    15, 30, 60 days

  • Variation of quality of life

    15, 30, 60 days

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with chronic pain treated with ketamine infusion

You may qualify if:

  • \- Pain lasting for more than six months without contraindication to treatment

You may not qualify if:

  • Inability to give consent
  • Severe psychiatric disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Princesse Grace

Monaco, 98000, Monaco

Location

MeSH Terms

Conditions

Chronic PainPainNeuralgiaFibromyalgiaMusculoskeletal Diseases

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesMuscular DiseasesRheumatic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2023

First Posted

November 15, 2023

Study Start

February 22, 2022

Primary Completion

August 6, 2024

Study Completion

August 6, 2024

Last Updated

February 19, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations

MO(1)